IJE Advance Access published online on January 19, 2008
International Journal of Epidemiology, doi:10.1093/ije/dym289
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Published by Oxford University Press on behalf of the International Epidemiological Association © The Author 2008; all rights reserved.
Editor's Choice |
Big business, big science?
E-mail: George.Davey-Smith@bris.ac.uk
| The first 10% of the full text of this article appears below. |
What is the appropriate nature of the relationship between researchers and their sponsors or employers? This question receives an energetic outing in the current issue of the IJE. Neil Pearce—president elect of the International Epidemiological Association (IEA), the organization for which the IJE is produced—makes a compelling case that corporate influences can distort the knowledge base of epidemiology.1 He relates the story of how research on the adverse effects of an asthma drug, fenoterol, was attacked by epidemiologists working as the hired guns of industry,